DK136385A - Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer - Google Patents

Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer Download PDF

Info

Publication number
DK136385A
DK136385A DK136385A DK136385A DK136385A DK 136385 A DK136385 A DK 136385A DK 136385 A DK136385 A DK 136385A DK 136385 A DK136385 A DK 136385A DK 136385 A DK136385 A DK 136385A
Authority
DK
Denmark
Prior art keywords
surfactors
ionogen
mixtures
dosage form
water soluble
Prior art date
Application number
DK136385A
Other languages
English (en)
Other versions
DK164484B (da
DK136385D0 (da
DK164484C (da
Inventor
Norman Grant Gaylord
Joseph Martin Schor
Original Assignee
Forest Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories filed Critical Forest Laboratories
Publication of DK136385D0 publication Critical patent/DK136385D0/da
Publication of DK136385A publication Critical patent/DK136385A/da
Publication of DK164484B publication Critical patent/DK164484B/da
Application granted granted Critical
Publication of DK164484C publication Critical patent/DK164484C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK136385A 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen DK164484C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/592,570 US4795327A (en) 1984-03-26 1984-03-26 Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US59257084 1984-03-26

Publications (4)

Publication Number Publication Date
DK136385D0 DK136385D0 (da) 1985-03-26
DK136385A true DK136385A (da) 1985-09-27
DK164484B DK164484B (da) 1992-07-06
DK164484C DK164484C (da) 1992-11-16

Family

ID=24371220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK136385A DK164484C (da) 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen

Country Status (9)

Country Link
US (1) US4795327A (da)
EP (1) EP0157695B1 (da)
JP (1) JPS60218329A (da)
CA (1) CA1240925A (da)
DE (1) DE3583694D1 (da)
DK (1) DK164484C (da)
ES (1) ES8607009A1 (da)
PL (1) PL144347B1 (da)
YU (1) YU45915B (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
EP0297866A3 (en) * 1987-07-01 1989-12-13 The Boots Company PLC Therapeutic agents
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
EP0489096B1 (en) * 1989-08-25 1995-11-15 BIOGLAN IRELAND (R & D) LIMITED Pharmaceutical compositions and a device for administering the same
FR2656525A1 (fr) * 1989-12-29 1991-07-05 Delalande Sa Formes d'administration de medicament a liberation controlee et leur procede de fabrication.
SE466130B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
SE9003904D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Method for the manufacture of a pharmaceutical dosage form
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
JP3739410B2 (ja) 1997-07-02 2006-01-25 ユーロ−セルティーク エス．エイ． 安定化された徐放性トラマドール製剤
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
FR2766707A1 (fr) * 1997-07-30 1999-02-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethyl-cellulose et/ou de l'ethylcellulose a titre d'agents desintegrants, et procede d'obtention
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2000033818A1 (en) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
EP2422772A3 (en) * 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR101486228B1 (ko) * 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
JP2010506833A (ja) * 2006-10-11 2010-03-04 アルファーマ，インコーポレイテッド 医薬組成物
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
EP2155170A2 (en) * 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US9464227B2 (en) * 2014-03-24 2016-10-11 Lamberti Spa Moisturizing agents
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
EP3609467B1 (en) * 2017-04-13 2024-02-28 The Procter & Gamble Company Method of preparing a product composition comprising a discrete particle and an aqueous base composition
WO2020014738A1 (en) * 2018-07-17 2020-01-23 Ferromedica Pty Ltd Ferrous sulphate formulations and uses thereof
US11931441B2 (en) 2018-10-10 2024-03-19 The Procter & Gamble Company Personal care product customized by discrete particles and method of apply thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
EP0157695A2 (en) 1985-10-09
YU45915B (sh) 1992-09-07
DE3583694D1 (de) 1991-09-12
YU49585A (en) 1990-12-31
JPS60218329A (ja) 1985-11-01
CA1240925A (en) 1988-08-23
PL252614A1 (en) 1985-12-17
EP0157695A3 (en) 1987-05-13
DK164484B (da) 1992-07-06
EP0157695B1 (en) 1991-08-07
US4795327A (en) 1989-01-03
ES541503A0 (es) 1986-05-16
PL144347B1 (en) 1988-05-31
ES8607009A1 (es) 1986-05-16
DK136385D0 (da) 1985-03-26
DK164484C (da) 1992-11-16

Similar Documents

Publication Publication Date Title
DK136385A (da) Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer
DK546886A (da) Farmaceutisk praeparat til reguleret frigoerelse af aktive stoffer
DE3676235D1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe.
IT1153437B (it) Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
ZA821196B (en) Substituted benzimidazolones and salts thereof, methods of preparation and pharmaceutical compositions thereof
NL190923C (nl) Farmaceutisch preparaat omvattende ibuprofen en caffeine.
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
IT8149623A0 (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
FR2580632B1 (fr) Ethers cyclopentiliques, leur preparation et formulation pharmaceutiques les contenant
IT1193529B (it) Derivati adenosinici ad attivita' antinfiammatoria ed analgesica e composizioni terapeutiche che li contengono come principio attivo
FR2532310B1 (fr) Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent
IT1167276B (it) Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia
MA19907A1 (fr) Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques.
MA19893A1 (fr) Procede de preparation de derives de sulfamoylbenzophenone et utilisation de ceux-ci dans des compositions pharmaceutiques.
IT8224306A0 (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia.
IT1168389B (it) Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
IT1150194B (it) Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva
IT1172127B (it) Tioacil - carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono ad azione mucclitica
DE3061830D1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions
BE882841A (fr) Nouvelle substance biologiquement active, sa preparation et les medicaments qui la contiennent
ZA849442B (en) Sphingosine derivatives,their preparation and pharmaceutical formulation
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT1200472B (it) Derivati chinolinici,loro preparazione e composizioni terapeutiche che li contengono

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK